Arian Foster IPO gets sidelined

The offering has been postponed because Foster suffered a back injury and will sit out the rest of the season.

By InvestorPlace Nov 14, 2013 12:40PM

File photo of Arian Foster of the Houston Texans on December 16, 2012 (© Scott Halleran/Getty Images)By Tom Taulli


It certainly was a unique idea: Startup company Fantex entered into an agreement with Arian Foster (pictured), star running back for the Houston Texans, to get 20% of his career earnings in exchange for a $10 million upfront fee.


The purpose: To launch an initial public offering of sorts in the running back, in which people could buy and sell Arian Foster stock.


The company started putting together the necessary papers for an IPO, but things didn't go as planned. The deal has been postponed because Foster suffered a back injury in his latest game. He’ll have to get surgery for a ruptured disc and sit out the rest of the season.


The timing couldn’t have been worse, and now it seems likely that the idea of an athlete-backed IPO may never be a reality.


Fantex had also been planning an offering for Vernon Davis, a tight end for the San Francisco 49ers. However, Davis had to leave the game this Sunday because of a concussion, raising questions about the viability of an IPO for the tight end.


Let’s face it, IPOs are already fraught with risks, as seen with recent deals like Tremor Video (TRMR) and Violin Memory (VMEM). Just look at this week’s offering from Chegg (CHGG), which is down 15%.


The IPO market is not for conservative investors.


With an offering is based on the performance of an NFL player, the risk levels are probably even too much -- even for risky investors. Besides, if people want to bet on the fortunes of the game, they can sign up for the myriad of fantasy leagues, right?


So while Fantex should be commended for being innovative, not every good idea works in practice. And when it comes to football, it’s probably best for players like Arian Foster to stick to their game on the field, not the experimental stock markets.


More From InvestorPlace

Tom Taulli runs the InvestorPlace blog IPO Playbook. He is also the author of High-Profit IPO StrategiesAll About Commodities and All About Short Selling. As of this writing, he did not hold a position in any of the aforementioned securities.

0Comments

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

113
113 rated 1
279
279 rated 2
416
416 rated 3
647
647 rated 4
548
548 rated 5
513
513 rated 6
669
669 rated 7
516
516 rated 8
317
317 rated 9
113
113 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
KOGKODIAK OIL & GAS Corp10
UPLULTRA PETROLEUM Corp10
TAT&T Inc9
COPCONOCOPHILLIPS9
DVNDEVON ENERGY CORPORATION9
More

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.